Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Report 2021
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Report 2021
The Sodium Glucose Cotransporter 2 (SGLT 2) Inhibitors Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industries have also been greatly affected.
In the past few years, the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market experienced a growth of xx, the global market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors reached xx million $ in 2020, of what is about xx million $ in 2015.
From 2015 to 2019, the growth rate of global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size in 2020 will be xx with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size will reach xx million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)
Industry Segmentation
Hospital
Medical Research Institute
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Definition
Section 2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments
2.2 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Revenue
2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Overview
2.4 COVID-19 Impact on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry
Section 3 Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.1 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.1.1 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution by Region
3.1.3 Eli Lilly Interview Record
3.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Profile
3.1.5 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
3.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.2.1 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution by Region
3.2.3 Interview Record
3.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Overview
3.2.5 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.3.1 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution by Region
3.3.3 Interview Record
3.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Overview
3.3.5 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
3.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.5 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
3.6 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
…
Section 4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.1.2 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.3.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.3.3 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.3.4 Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.4.2 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.4.3 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.4.4 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.4.5 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.5.2 Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.5.3 GCC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Price Analysis 2015-2020
4.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Region Level) Analysis
Section 5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Product Type Level)
5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type Price 2015-2020
5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Product Type Level) Analysis
Section 6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Industry Level)
6.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Industry Level) Analysis
Section 7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Channel Level)
7.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Channel Level) Analysis
Section 8 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast 2020-2025
8.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Region Level)
8.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Product Type Level)
8.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Industry Level)
8.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Channel Level)
Section 9 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Product Type
9.1 Invokana (Canagliflozin) Product Introduction
9.2 Jardiance (Empagliflozin) Product Introduction
9.3 Farxiga/Forxiga (Dapagliflozin) Product Introduction
9.4 Suglat (Ipragliflozin) Product Introduction
Section 10 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Industry
10.1 Hospital Clients
10.2 Medical Research Institute Clients
Section 11 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture from Eli Lilly
Chart 2015-2020 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments (Units)
Chart 2015-2020 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments Share
Chart 2015-2020 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Revenue Share
Chart Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments, Price, Revenue and Gross profit 2015-2020
Chart Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution
Chart Eli Lilly Interview Record (Partly)
Figure Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture
Chart Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Profile
Table Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
Chart Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments, Price, Revenue and Gross profit 2015-2020
Chart Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution
Chart Janssen Pharmaceuticals Interview Record (Partly)
Figure Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture
Chart Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Overview
Table Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
Chart Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Shipments, Price, Revenue and Gross profit 2015-2020
Chart Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Distribution
Chart Astellas Interview Record (Partly)
Figure Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture
Chart Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Overview
Table Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Specification
3.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Introduction
…
Chart United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Middle East Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart GCC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price ($/Unit) 2015-2020
Chart Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Region Level) Market size 2015-2020
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type Price ($/Unit) 2015-2020
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentation (Channel Level) Share 2015-2020
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Region Level) 2020-2025
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Industry Level) 2020-2025
Chart Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segmentation Market Forecast (Channel Level) 2020-2025
Chart Invokana (Canagliflozin) Product Figure
Chart Invokana (Canagliflozin) Product Advantage and Disadvantage Comparison
Chart Jardiance (Empagliflozin) Product Figure
Chart Jardiance (Empagliflozin) Product Advantage and Disadvantage Comparison
Chart Farxiga/Forxiga (Dapagliflozin) Product Figure
Chart Farxiga/Forxiga (Dapagliflozin) Product Advantage and Disadvantage Comparison
Chart Suglat (Ipragliflozin) Product Figure
Chart Suglat (Ipragliflozin) Product Advantage and Disadvantage Comparison
Chart Hospital Clients
Chart Medical Research Institute Clients
Research Methodology:
Sodium Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|